Articulinx Receives $700,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1601 S. De Anza Blvd. Cupertino, CA 95014
  • Company Description
    Articulinx leverages unique material properties to create a new type of implant. Delivered minimally-invasively, the device does not sacrifice native tissue nor bone and may be implanted earlier in the disease process. The tissue-sparing / bone-preserving nature of the device also allows for the procedure to be reversed if desired.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    U.S. Venture Partners

Trending on Xconomy